Address
Technology Partners.
550 University Avenue
Palo Alto, CA 94301
United States
Phone
Recent investment activity
KANDO id: 28603
Corporate information
Registration country
Company type
Venture capital firmFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Technology Partners Fund VII LP | ||||
| Technology Partners Fund VI LP | ||||
| Technology Partners Fund V LP |
Funding rounds
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 13 of 13| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series D | ||||
| Encirq Corp | Series A | |||||
| Incline Therapeutics Inc | Patient controlled analgesia | Series A | ||||
| Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | ||||
|
NanoGram Corp | Maker of core process technology for the manufacture of nanostructured materials for optical, electronic and energy applications | Venture led the round | |||
| Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Venture | ||||
| Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Series D | ||||
| Rinat Neuroscience Corp | Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases | Series B Follow-on investment | ||||
| Rinat Neuroscience Corp | Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases | Series A Initial investment | ||||
| TRIA Beauty Inc | Venture | |||||
| TRIA Beauty Inc | Series E | |||||
| TRIA Beauty Inc | Series D | |||||
| Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Series D |